Zacks Investment Research on MSN

Is it the right time to add Insulet stock to your portfolio?

Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...

Medtronic’s diabetes spinoff MiniMed files for IPO

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

Insulet’s New Omnipod M Study Targets the Untapped Type 2 Diabetes Pump Market

Insulet Corporation is running a new clinical study titled “An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes.” The goal is to see if its next-generation Omnipod M system is ...

Insulet’s Omnipod SmartAdjust 2.0 Trial Wraps Up: What Investors Should Watch Next

Insulet’s new study, officially titled “Safety and Efficacy of the Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes,” compares an ...
Yahoo Finance

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

ACTON, Mass., December 15, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with its Omnipod brand of ...
The Caledonian Record

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) ...
MarketWatch

Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital Diabetes Management Transform Patient Care

The MarketWatch News Department was not involved in the creation of this content. Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital ...
Insider Monkey

Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating

With significant upside potential, Insulet Corporation (NASDAQ:PODD) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 29, given Insulet ...
TMCnet

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Omnipod Mango breaks away from the world of traditional blues that dominate the medical and diabetes landscapes. An uplifting orange hue, Omnipod Mango embodies the feeling of liberation that its ...
The Daily News

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, and Pantone ®, the global authority on color ...
GitHub

Too frequent basal updates may cause basal insulin delivery problems with Omnipod Dash

AAPS version 3.3.1.3 Using closed loop with SMB enabled Pump: Omnipod Dash Glucose sensor: FSL3 BG values coming every 1 minute from Juggluco Too frequent basal rate changes may cause basal insulin ...